Bicara Therapeutics's top three insider shareholders as of August 29, 2026 are Kiran Mazumdar-Shaw (Director, 6.28Mn shares), Ltd Biocon (TenPercentOwner, 5.52Mn shares), Ltd Biocon (TenPercentOwner, 5.52Mn shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Kiran Mazumdar-Shaw | Director, TenPercentOwner | 0 | 6,281,185 | 6,281,185 | 38.6% | 16 Sep, 2024 |
| 2 | Ltd Biocon | TenPercentOwner | 0 | 5,523,897 | 5,523,897 | 33.9% | 16 Sep, 2024 |
| 3 | Gp A, Llc Tpg | Other | 0 | 1,960,425 | 1,960,425 | 12.0% | 18 Sep, 2024 |
| 4 | James E Flynn | TenPercentOwner, Other | 0 | 1,795,174 | 1,795,174 | 11.0% | 17 Sep, 2024 |
| 5 | Claire Mazumdar | Chief Executive Officer | 362,152 | 0 | 362,152 | 2.2% | 14 Jul, 2026 |
| 6 | Ryan Cohlhepp | President And Coo | 181,641 | 0 | 181,641 | 1.1% | 12 Aug, 2026 |
| 7 | Ivan Hyep | Chief Financial Officer | 129,855 | 0 | 129,855 | 0.8% | 12 Aug, 2026 |
| 8 | David Raben | Chief Medical Officer | 55,286 | 0 | 55,286 | 0.3% | 28 Apr, 2026 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 12 Aug, 2026 | Jennifer Larson | Chief Financial Officer | Acquired A | 285,000 | $0.00 | $0 | 285,000 | Direct |
| 10 Aug, 2026 | Ryan Cohlhepp | President And Coo | Acquired M | 18,750 | $3.79 | $71.06K | 200,391 | Direct |
| 10 Aug, 2026 | Ivan Hyep | Chief Financial Officer | Acquired M | 12,500 | $3.79 | $47.37K | 142,355 | Direct |
| 10 Aug, 2026 | Ryan Cohlhepp | President And Coo | Disposed S | 18,750 | $27.98 | $524.53K | 181,641 | Direct |
| 10 Aug, 2026 | Ivan Hyep | Chief Financial Officer | Disposed S | 12,500 | $27.97 | $349.59K | 129,855 | Direct |
| 10 Aug, 2026 | Ryan Cohlhepp | President And Coo | Disposed M | 18,750 | $0.00 | $0 | 51,752 | Direct |
| 10 Aug, 2026 | Ivan Hyep | Chief Financial Officer | Disposed M | 12,500 | $0.00 | $0 | 26,336 | Direct |
| 28 Jul, 2026 | Christy J. Oliger | Director | Acquired A | 38,950 | $0.00 | $0 | 38,950 | Direct |
| 28 Jul, 2026 | Jeremy Bender | Director | Acquired A | 38,950 | $0.00 | $0 | 38,950 | Direct |
| 10 Jul, 2026 | Claire Mazumdar | Chief Executive Officer | Acquired M | 10,000 | $3.79 | $37.90K | 372,152 | Direct |
| 10 Jul, 2026 | Claire Mazumdar | Chief Executive Officer | Disposed S | 9,972 | $28.42 | $283.37K | 362,180 | Direct |
| 10 Jul, 2026 | Claire Mazumdar | Chief Executive Officer | Disposed S | 28 | $29.68 | $831 | 362,152 | Direct |
| 10 Jul, 2026 | Claire Mazumdar | Chief Executive Officer | Disposed M | 10,000 | $0.00 | $0 | 120,546 | Direct |
| 08 Jul, 2026 | Ryan Cohlhepp | President And Coo | Acquired M | 18,750 | $3.79 | $71.06K | 210,391 | Direct |
| 08 Jul, 2026 | Ivan Hyep | Chief Financial Officer | Acquired M | 12,500 | $3.79 | $47.37K | 157,855 | Direct |
| 08 Jul, 2026 | Ryan Cohlhepp | President And Coo | Disposed S | 22,833 | $28.76 | $656.65K | 187,558 | Direct |
| 08 Jul, 2026 | Ivan Hyep | Chief Financial Officer | Disposed S | 22,757 | $28.60 | $650.90K | 135,098 | Direct |
| 08 Jul, 2026 | Ivan Hyep | Chief Financial Officer | Disposed S | 4,413 | $29.82 | $131.62K | 130,685 | Direct |
| 08 Jul, 2026 | Ryan Cohlhepp | President And Coo | Disposed S | 4,306 | $29.80 | $128.30K | 183,252 | Direct |
| 08 Jul, 2026 | Ryan Cohlhepp | President And Coo | Disposed S | 1,075 | $30.35 | $32.63K | 182,177 | Direct |